Literature DB >> 44929

The role of adrenergic receptors in the regulation of gastric motility in the rat.

T Gáti, F Gelencsér, J Hideg.   

Abstract

Gastric motility was investigated under the effect of adrenergic receptor agonist and antagonist substances in albino rats of both sexes and weighing 150 to 180 g. Gastric evacuation was studied, after introducing 2 ml/100 g of Novobarium suspension in the stomach, by radioscopy and radiography. Epinephrine (Tonogen) was found to inhibit gastric motility, this inhibition being effective even after pylorotomy. The dominantly alpha adrenergic agonist phenylephrine (Sympathomim) had not any effect; the alpha blocker phenoxybenzamine (Dibenzyline) slightly depressed gastric evaluation. A marked inhibitory influence was noted with stimulating the beta receptors by isoproterenol (Prophylon), while propranolol (Inderal) slightly accelerated gastric evacuation by blocking beta receptors. A pretreatment by phenoxybenzamine of the animals did not affect epinephrine influence whereas a pretreatment by propranolol completely abolished the inhibitory effect of epinephrine on gastric motility. These results suggest the presence of a slight beta receptor tone in gastric motility at rest, and indicate further that epinephrine exerts its inhibitory effect on gastric motility via adrenergic beta receptors.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 44929

Source DB:  PubMed          Journal:  Z Exp Chir        ISSN: 0323-5580


  4 in total

1.  Antro-pyloro-duodenal motor responses to gastric and duodenal nutrient in critically ill patients.

Authors:  M Chapman; R Fraser; R Vozzo; L Bryant; W Tam; N Nguyen; B Zacharakis; R Butler; G Davidson; M Horowitz
Journal:  Gut       Date:  2005-05-29       Impact factor: 23.059

2.  Impact of disease severity on gastric residual volume in critical patients.

Authors:  Chien-Wei Hsu; Shu-Fen Sun; David Lin Lee; Shoa-Lin Lin; Kam-Fai Wong; Hsiu-Hua Huang; Hung-Ju Li
Journal:  World J Gastroenterol       Date:  2011-04-21       Impact factor: 5.742

3.  Targeted Inhibition of Gut Microbial Trimethylamine N-Oxide Production Reduces Renal Tubulointerstitial Fibrosis and Functional Impairment in a Murine Model of Chronic Kidney Disease.

Authors:  Nilaksh Gupta; Jennifer A Buffa; Adam B Roberts; Naseer Sangwan; Sarah M Skye; Lin Li; Karen J Ho; John Varga; Joseph A DiDonato; W H Wilson Tang; Stanley L Hazen
Journal:  Arterioscler Thromb Vasc Biol       Date:  2020-03-26       Impact factor: 8.311

4.  Gastrointestinal dysfunction during enteral nutrition delivery in intensive care unit (ICU) patients: Risk factors, natural history, and clinical implications. A post-hoc analysis of The Augmented versus Routine approach to Giving Energy Trial (TARGET).

Authors:  Tejaswini Arunachala Murthy; Lee-Anne S Chapple; Kylie Lange; Chinmay S Marathe; Michael Horowitz; Sandra L Peake; Marianne J Chapman
Journal:  Am J Clin Nutr       Date:  2022-08-04       Impact factor: 8.472

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.